Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy

被引:0
|
作者
Ioannis Kyriakidis
Paraskevi Papaioannidou
机构
[1] Aristotle University of Thessaloniki,Department of Pharmacology, Medical School
来源
关键词
Estrogen receptor beta (ERβ); Ovarian cancer; ESR2; ER beta isoforms; ER beta polymorphisms; Epigenetic modifications; Pharmacogenomics;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1161 / 1168
页数:7
相关论文
共 50 条
  • [1] Estrogen receptor beta and ovarian cancer: a key to pathogenesis and response to therapy
    Kyriakidis, Ioannis
    Papaioannidou, Paraskevi
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2016, 293 (06) : 1161 - 1168
  • [2] Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy
    Gallo, Daniela
    De Stefano, Ilaria
    Prisco, Maria Grazia
    Scambia, Giovanni
    Ferrandina, Gabriella
    CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (19) : 2734 - 2757
  • [3] Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
    Liu, Jinyou
    Viswanadhapalli, Suryavathi
    Garcia, Lauren
    Zhou, Mei
    Nair, Binoj C.
    Kost, Edward
    Tekmal, Rajeshwar Rao
    Li, Rong
    Rao, Manjeet K.
    Curiel, Tyler
    Vadlamudi, Ratna K.
    Sareddy, Gangadhara R.
    ONCOTARGET, 2017, 8 (30) : 50002 - 50014
  • [4] Potential Role of Estrogen Receptor Beta as a Tumor Suppressor of Epithelial Ovarian Cancer
    Bossard, Carine
    Busson, Muriel
    Vindrieux, David
    Gaudin, Francoise
    Machelon, Veronique
    Brigitte, Madly
    Jacquard, Carine
    Pillon, Arnaud
    Balaguer, Patrick
    Balabanian, Karl
    Lazennec, Gwendal
    PLOS ONE, 2012, 7 (09):
  • [5] Cancer therapy using natural ligands that target estrogen receptor beta
    Gangadhara R Sareddy
    Ratna K.Vadlamudi
    Chinese Journal of Natural Medicines, 2015, 13 (11) : 801 - 807
  • [6] Cancer therapy using natural ligands that target estrogen receptor beta
    Sareddy, Gangadhara R.
    Vadlamudi, Ratna K.
    CHINESE JOURNAL OF NATURAL MEDICINES, 2015, 13 (11) : 801 - 807
  • [7] Estrogen replacement therapy and ovarian cancer
    Folsom, AR
    Anderson, JP
    Ross, JA
    EPIDEMIOLOGY, 2004, 15 (01) : 100 - 104
  • [8] Estrogen replacement therapy and ovarian cancer
    Sittisomwong, T
    Suneja, A
    Kudelka, AP
    Verschraegen, CF
    Kavanagh, JJ
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2000, 21 (04) : 348 - 354
  • [9] Estrogen Receptor Beta, but Not Alpha, is the Key Player in Restoration of Heart Function of Heart Failure Mice by Estrogen Therapy
    Iorga, Andrea
    Partow-Navid, Rod
    Nadadur, Rangarajan
    Matori, Humann
    Li, Jingyuan
    Umar, Soban
    Eghbali, Mansoureh
    BIOPHYSICAL JOURNAL, 2011, 100 (03) : 295 - 296
  • [10] Estrogen receptor beta in breast cancer
    Palmieri, C
    Cheng, GJ
    Saji, S
    Zelada-Hedman, M
    Wärri, A
    Weihua, Z
    Van Noorden, S
    Wahlstrom, T
    Coombes, RC
    Warner, M
    Gustafsson, JÅ
    ENDOCRINE-RELATED CANCER, 2002, 9 (01) : 1 - 13